Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $272,030 - $348,766
4,606 New
4,606 $340,000
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $67,771 - $118,683
2,233 Added 0.67%
336,221 $16.6 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $269,251 - $415,794
8,422 Added 2.59%
333,988 $10.9 Million
Q2 2022

Aug 12, 2022

BUY
$35.61 - $76.23 $10.2 Million - $21.8 Million
286,241 Added 727.89%
325,566 $12.8 Million
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $1.51 Million - $2.16 Million
-26,177 Reduced 39.96%
39,325 $2.75 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $15.9 Million - $22.1 Million
-219,187 Reduced 76.99%
65,502 $5.1 Million
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $9.92 Million - $13.6 Million
109,877 Added 62.85%
284,689 $27.2 Million
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $65.2 Million - $97 Million
-696,330 Reduced 79.93%
174,812 $21.7 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $22 Million - $29.3 Million
-188,825 Reduced 17.81%
871,142 $115 Million
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $5.95 Million - $8.49 Million
-59,766 Reduced 5.34%
1,059,967 $140 Million
Q3 2020

Nov 12, 2020

BUY
$72.92 - $102.01 $81.7 Million - $114 Million
1,119,733 New
1,119,733 $114 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.58B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.